Drug Profile
AZD 7545
Latest Information Update: 23 Jan 2003
Price :
$50
*
At a glance
- Originator AstraZeneca
- Class
- Mechanism of Action Pyruvate kinase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Diabetes mellitus
Most Recent Events
- 23 Jan 2003 Discontinued for Diabetes mellitus in Europe (unspecified route)
- 18 Jan 2002 Investigation in Diabetes mellitus in Europe (Unknown route)